Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.5K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cross-regional assessment of heavy metal contamination and Cd exceedance risk in specialty vegetable-producing soils across China.

Environmental research·2026
Same author

Advances in ligand-targeted nanodelivery systems for leukemia therapy: from single- to dual-ligand strategies.

Journal of translational medicine·2026
Same author

A 13-kb Deletion in SeAPRR2 Disrupts Chloroplast Development by Dual-Targeting SeHEMA1/SeLHCB4 for White Peel Formation in Chayote.

Plant, cell & environment·2026
Same author

CsBZR4-CsRBOH5.1-BR module regulates opening/closure and expansion of cucumber cotyledons.

International journal of biological macromolecules·2025
Same author

Genome-wide analysis of H3K27me3 in cucumber during recovery after cold stress priming.

Plant physiology and biochemistry : PPB·2025
Same author

Smart Nanoarchitectures for Precision RNA Delivery: Harnessing Endogenous and Exogenous Stimuli in Cancer Treatment.

Theranostics·2025

相关实验视频

Updated: May 30, 2025

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.4K

创新性脂质纳米颗粒共释放氧化和siRNA,用于增强性风湿性关节炎治疗.

Yanru Feng1, Xintong Pan1, Ziqian Li1

  • 1Department of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang 050017, China.

Pharmaceutics
|January 25, 2025
PubMed
概括

这项研究引入了用于类风湿性关节炎 (RA) 治疗的新型脂质纳米颗粒,同时提供氧化和抗TNF-α siRNA. 双输送系统在临床前模型中有效降低了炎症,显示了加强RA治疗的前景.

关键词:
共同交付是一种共同交付.氧化chloroquine 的使用情况脂质纳米颗粒是一种纳米粒子.类风湿性关节炎 类风湿性关节炎这就是siTNF-α.

更多相关视频

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.4K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.1K

相关实验视频

Last Updated: May 30, 2025

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
10:33

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

10.4K
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.4K
Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.1K

科学领域:

  • 生物技术是生物技术.
  • 纳米医学是一种纳米医学.
  • 免疫学 免疫学 免疫学

背景情况:

  • 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,导致关节炎症和损伤.
  • 目前的RA治疗方法往往无法实现完全缓解.
  • 需要创新的治疗策略来改善RA管理.

研究的目的:

  • 开发和评估一种新的脂质纳米颗粒 (LNP) 配方,用于同时提供氧化 (HCQ) 和向TNF-α (siTNF-α) 的siRNA.
  • 通过关节内给药来评估这种通过关节内给药来治疗类风湿性关节炎的双输送系统的疗效和安全性.

主要方法:

  • 利用微流体技术创建LNP,同时提供HCQ和siTNF-α.
  • 在LPS刺激的RAW 264.7细胞中评估了LNP的抗炎作用.
  • 评估了RA的老鼠模型中的关节内LNP注射的治疗疗效和生物安全性.

主要成果:

  • 开发的LNP在体外有效降低了炎症标志物.
  • 在老鼠模型中,LNP的关节内给药显著降低了关节炎症.
  • 新型LNP配方在体内表现出良好的生物安全性.

结论:

  • 这项研究首次使用脂质纳米颗粒平台,同时提供HCQ和siTNF-α用于RA治疗.
  • 针对性的双重作用LNP的关节内输送显示了增强类风湿性关节炎治疗的显著潜力.
  • 脂质纳米颗粒为治疗慢性炎症关节疾病提供了一个有前途的双交付策略.